Global Live Biotherapeutic Products And Microbiome Contract Manufacturing Market

Report ID : 1152 | Published : 2021-07-27 | Pages: 140 | Format:

The Human Microbiome is the group of loads of microbes living on and in the human body. The microbiomes are found, for example, in the skin, gut, mouth, and vagina.  A live biotherapeutic product comprises a live microorganism used for the cure or treatment and prevention of disease. The live biotherapeutic industry is experiencing enormous research and development activities to develop products for various diseases and applications. The global market for live biotherapeutic products and microbiome contract manufacturing was valued at US$ 403.7 Mn in 2019, recording a promising CAGR of 6.3% during the period of 2019-2030.

Till now, about 200 companies are developing microbiome-based therapies anticipated to treat an extensive range of severe diseases, with big pharmaceutical companies showing augmented interest by associating with early innovators. Most of the clinical treatment is under the preclinical stage, various are under clinical development, and about 15 are in phase II/III trials of development. The commercialization of these products in the coming years is expected to generate a huge potential for the growth of the market over the estimated timeframe. However, the lack of a satisfactory manufacturing capacity of the innovators may significantly hinder the market's growth. Additionally, lack of the essential industry standards associated with live biotherapeutics manufacturing, batch-to-batch reliability-related concerns, lack of infrastructure, and uncertainties related to product approval and regulatory review are some of the factors affecting market growth substantially. However, a growing number of deals among various developers for contract manufacturing is projected to generate immense opportunities for the market's growth globally.

The Global Live Biotherapeutic Products and Microbiome Contract Manufacturing Market is segmented on the basis of product manufactured, type of formulation, the scale of operation, company size, and region. The market is divided into Active Pharmaceutical Ingredients (APIs) and Finished Drug Formulations (FDFs) based on the product manufactured. Based on the type of formulation, the market is segmented into solid formulations, oral liquids, injectables, and others. Based on the scale of operation, the market is categorized into, preclinical scale operations, clinical scale operations, and commercial-scale operations. By company size, live biotherapeutic products and microbiome contract manufacturing market is segmented into small-sized companies, mid-sized companies, and large companies. Based on the region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA.

The key players of this market include Quay Pharmaceuticals, Cobra Biologics Limited, Cerbios-Pharma SA, List Biological Labs, Inc., Arranta Bio, BacThera, Luina Bio Pty Ltd, 4D pharma plc, Paras Biopharmaceuticals Finland Oy, Capsugel, Deerland Probiotics & Enzymes, Paragon Bioservices, UAS Labs, Biose, Cobra Biologics, Cerbios, Inpac Probiotics, BJP Laboratories, S-Biomedic, Meteoric Biopharmaceuticals, BiomX, Universal Stabilization Technologies, Assembly Biosciences, Wacker Biotech,  and Chung Mei Pharmaceutical. The live biotherapeutic products and microbiome contract manufacturing market has several players across the globe. The growing research and development activities and growing partnerships among the key players operating in the market to seek different companies' platforms are expected to boost the market significantly in the coming years.

  • Arranta Bio
  • Cobra Biologics Limited
  • Cerbios-Pharma SA
  • List Biological Labs, Inc.
  • BacThera
  • Luina Bio Pty Ltd
  • 4D pharma plc
  • BiomX
  • Paras Biopharmaceuticals Finland Oy
  • Capsugel
  • Deerland Probiotics & Enzymes
  • Paragon Bioservices
  • UAS Labs
  • Biose
  • Cobra Biologics
  • Cerbios
  • Inpac Probiotics
  • BJP Laboratories
  • S-Biomedic
  • Meteoric Biopharmaceuticals
  • Universal Stabilization Technologies
  • Assembly Biosciences
  • Wacker Biotech
  • Quay Pharmaceuticals
  • Chung Mei Pharmaceutical

Global Live Biotherapeutic Products and Microbiome Contract Manufacturing Market Segmentation:

Global Live Biotherapeutic Products and Microbiome Contract Manufacturing Market by Product Manufactured

  • APIs
  • FDFs

Global Live Biotherapeutic Products and Microbiome Contract Manufacturing Market Based on Type of Formulation

  • Solid Formulations
  • Oral Liquids
  • Injectables
  • Others

Global Live Biotherapeutic Products and Microbiome Contract Manufacturing Market Based on Scale of Operation

  • Preclinical Scale Operations
  • Clinical Scale Operations
  • Commercial Scale Operations

Global Live Biotherapeutic Products and Microbiome Contract Manufacturing Market Based on Company Size

  • Small-sized Companies
  • Mid-sized Companies
  • Large Companies

Global Live Biotherapeutic Products and Microbiome Contract Manufacturing Market Based on Region

Europe

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America

  • U.S.
  • Canada

Asia Pacific

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients